Your browser doesn't support javascript.
loading
Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs.
Duhem, Nicolas; Rolland, Julien; Riva, Raphaël; Guillet, Pierre; Schumers, Jean-Marc; Jérome, Christine; Gohy, Jean-François; Préat, Véronique.
Afiliação
  • Duhem N; Université catholique de Louvain, Louvain Drug Research Institute, Pharmaceutics and Drug Delivery, Avenue Mounier, 73, B1.73.12, 1200 Brussels, Belgium. nicolas.duhem@uclouvain.be
Int J Pharm ; 423(2): 452-60, 2012 Feb 28.
Article em En | MEDLINE | ID: mdl-22212463
ABSTRACT
The aim of this study was to develop tocol derivatives of chitosan able (i) to self-assemble in the gastrointestinal tract and (ii) to enhance the solubility of poorly soluble drugs. Among the derivatives synthesized, tocopherol succinate glycol chitosan (GC-TOS) conjugates spontaneously formed micelles in aqueous solution with a critical micelle concentration of 2 µg mL(-1). AFM and TEM analysis showed that spherical micelles were formed. The GC-TOS increased water solubility of 2 model class II drugs. GC-TOS loading efficiency was 2.4% (w/w) for ketoconazole and 0.14% (w/w) for itraconazole, respectively. GC-TOS was non-cytotoxic at concentrations up to 10 mg mL(-1). A 3.4-fold increase of the apparent permeation coefficient of ketoconazole across a Caco-2 cell monolayer was demonstrated. Tocol polymer conjugates may be promising vehicles for the oral delivery of poorly soluble drugs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Itraconazol / Tocoferóis / Quitosana / Cetoconazol Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Itraconazol / Tocoferóis / Quitosana / Cetoconazol Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article